Curad Maximum Strength Triple Antibiotic
NDC 53329-031, bacitracin, neomycin, polymyxin B, pramoxine hydrochloride, ointment, from Medline Industries, LP.
- Product NDC
- 53329-031
- Status
- Listed
- Labeler
- Medline Industries, LP
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M004
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53329-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYMYXIN B SULFATE10000 [USP'U]/g
- NEOMYCIN SULFATE3.5 mg/g
- PRAMOXINE HYDROCHLORIDE10 mg/g
- BACITRACIN ZINC500 [USP'U]/g
Pharmacologic classes
Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Decreased Cell Wall Synthesis & Repair [PE]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53329-031-01 | 53329003101 | 1 TUBE in 1 BOX (53329-031-01) / 28.4 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 53329-031 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53329-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53329-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.